Loading organizations...
Loading organizations...
Sino MDT has raised $4.0M across 1 funding round.
Sino MDT has raised $4.0M in total across 1 funding round.
Sino MDT has raised $4.0M in total across 1 funding round.
Sino MDT's investors include Qiming Venture Partners.
Sino MDT (Sino Medical-Device Technology Co., Ltd.) is a high-tech medical equipment company specializing in the design and manufacture of advanced medical devices, including syringe and infusion pumps, mammography machines, and contrast media injectors. It primarily serves healthcare providers by delivering reliable, high-performance diagnostic and treatment equipment that addresses critical needs in medical imaging and infusion therapy. The company has established a strong reputation both domestically in China and internationally, driven by its focus on innovation, quality, and cost-effective solutions[1][4].
Founded in 2007 and headquartered in Shenzhen’s Nanshan District, Sino MDT emerged as a subsidiary of the Haier Group, leveraging strong corporate backing to fuel its growth. The founding team brought expertise in medical technology and engineering, focusing early on on digital mammography—a field in which they developed China’s first certified digital mammography system. Early milestones included participation in setting national mammography standards and strategic partnerships with international mammography brands, which helped the company gain traction and credibility in the medical device market[1][2][3].
Sino MDT rides the global trend toward digital transformation in medical diagnostics and minimally invasive treatment technologies. The timing is favorable due to increasing demand for early cancer detection (e.g., breast cancer screening via mammography), improved infusion therapies, and advanced imaging techniques. Market forces such as aging populations, rising healthcare expenditures, and government support for medical innovation in China and abroad work in Sino MDT’s favor. By contributing to national standards and collaborating internationally, Sino MDT influences the broader medical device ecosystem, pushing forward quality and technological advancement[1][3].
Looking ahead, Sino MDT is poised to expand its footprint in both domestic and international markets by leveraging its strong R&D foundation and strategic partnerships. Emerging trends such as AI integration in imaging, personalized medicine, and smart infusion systems will likely shape its product roadmap. As healthcare systems increasingly prioritize early diagnosis and efficient treatment delivery, Sino MDT’s influence and market share are expected to grow, reinforcing its role as a key player in medical technology innovation[1].
Sino MDT has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Series A in February 2013.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2013 | $4.0M Series A | Qiming Venture Partners |